Study how lung disease affects white blood cells
Treatments studied
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study looks at how lung disease changes a type of blood cell called white blood cells. It may help researchers understand what’s happening in the lungs and how to better monitor or treat lung problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and be able to give informed consent
- If you can get pregnant, have a negative pregnancy test
- Have a normal hemoglobin level (>12.5 g/dL) on the day of the study
- Do not currently smoke (no current smoking) and have a negative urine nicotine test
- Be at least 50 kg in body weight
- Avoid certain recent blood-related issues (no recent major blood transfusions/iron/erythropoietin; no low hemoglobin in the last 90 days; no large blood donation in the last 56 days)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new gene therapy called KB408 for people with alpha-1 antitrypsin deficiency (AATD). It aims to see if KB408 can help your body produce enough of the missing protein to protect your lungs and liver.
This study tests an experimental RNA-based medicine (AIR-001) for people with a genetic form of alpha-1 antitrypsin deficiency (AATD). It aims to see if the drug can help boost your body's own protective protein levels and may slow lung damage.
This study is looking at people with a specific mild form of alpha-1 antitrypsin deficiency (PiMZ) to understand how their lung disease progresses over time. It involves lung function tests and CT scans, and may help researchers learn more about the condition.
This study looks at how alpha-1 antitrypsin deficiency affects the liver in adults. It aims to learn more about the liver problems caused by this condition and may help find better ways to manage them.
This study looks at how the body's immune cells respond to damaged proteins in people with lung diseases. Researchers will take a small blood sample to study these immune responses, which could lead to better treatments.
This study examines how certain white blood cells behave in people with lung cancer or COPD. It aims to better understand the immune response, which could help develop new treatments.
Hear when a new Alpha 1-Antitrypsin Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.